Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 135

1.

The effects of perioperative inhaled iloprost on pulmonary hypertension with congenital heart disease.

Sung KW, Jeon YB, Kim NY, Park KY, Park CH, Choi CH, Choi DY.

Cardiology. 2013;126(4):224-9. doi: 10.1159/000354248. Epub 2013 Sep 25.

PMID:
24081196
2.

Hemodynamic effects of combination therapy with inhaled nitric oxide and iloprost in patients with pulmonary hypertension and right ventricular dysfunction after high-risk cardiac surgery.

Antoniou T, Koletsis EN, Prokakis C, Rellia P, Thanopoulos A, Theodoraki K, Zarkalis D, Sfyrakis P.

J Cardiothorac Vasc Anesth. 2013 Jun;27(3):459-66. doi: 10.1053/j.jvca.2012.07.020. Epub 2012 Oct 10.

PMID:
23063102
3.

Perioperative sildenafil therapy for pulmonary hypertension in infants undergoing congenital cardiac defect closure.

El Midany AA, Mostafa EA, Azab S, Hassan GA.

Interact Cardiovasc Thorac Surg. 2013 Dec;17(6):963-8. doi: 10.1093/icvts/ivt353. Epub 2013 Aug 28.

4.

Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanisms.

Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M.

Circulation. 2001 Jan 30;103(4):544-8.

5.
6.

Combination therapy of prostacyclin for pulmonary hypertension in congenital heart disease.

Durongpisitkul K, Jakrapanichakul D, Laohaprasitiporn D, Soongswang J, Chanthong P, Nana A.

J Med Assoc Thai. 2005 Nov;88 Suppl 8:S60-5.

PMID:
16856428
7.

[Immediately effects of inhaled aerosolised iloprost in adult patients with severe pulmonary hypertension secondary to congenital heart diseases].

Zhang CJ, Huang YG, Shen JJ, Huang T, Huang WH, Cui YL, Huang XS.

Zhonghua Xin Xue Guan Bing Za Zhi. 2011 Jan;39(1):65-8. Chinese.

PMID:
21418801
8.

Short- and long-term effects of inhaled iloprost therapy in children with pulmonary arterial hypertension.

Ivy DD, Doran AK, Smith KJ, Mallory GB Jr, Beghetti M, Barst RJ, Brady D, Law Y, Parker D, Claussen L, Abman SH.

J Am Coll Cardiol. 2008 Jan 15;51(2):161-9. doi: 10.1016/j.jacc.2007.09.031.

9.
10.

Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy.

Kramm T, Eberle B, Guth S, Mayer E.

Eur J Cardiothorac Surg. 2005 Dec;28(6):882-8. Epub 2005 Oct 19.

PMID:
16242948
11.

Aerosolized iloprost for postoperative pulmonary hypertensive crisis in children with congenital heart disease.

Limsuwan A, Wanitkul S, Khosithset A, Attanavanich S, Samankatiwat P.

Int J Cardiol. 2008 Oct 13;129(3):333-8. Epub 2007 Dec 21.

PMID:
18096256
12.

[Effects of inhaled aerosolized iloprost in adult patients with pulmonary arterial hypertension on right heart functions].

Guo XX, Tian Z, Liu YT, Wang Q, Li MT, Zeng XF, Zhu WL, Fang Q.

Zhonghua Yi Xue Za Zhi. 2011 Nov 1;91(40):2832-6. Chinese.

PMID:
22333544
13.

Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH Study Group.

Olschewski H, Ghofrani HA, Schmehl T, Winkler J, Wilkens H, Höper MM, Behr J, Kleber FX, Seeger W.

Ann Intern Med. 2000 Mar 21;132(6):435-43.

PMID:
10733442
14.

Inhaled nitric oxide versus aerosolized iloprost for the treatment of pulmonary hypertension with left heart disease.

Yin N, Kaestle S, Yin J, Hentschel T, Pries AR, Kuppe H, Kuebler WM.

Crit Care Med. 2009 Mar;37(3):980-6. doi: 10.1097/CCM.0b013e3181962ce6.

PMID:
19237907
15.

[Effect of nebulised iloprost combined with inhaled nitric oxide and oral sildenafil on lung transplant patients. Therapeutic efficacy in pulmonary hypertension during surgery].

Rabanal Llevot JM, Cimadevilla Calvo B, Cifrian Martinez JM, Ruisanchez Villar C, Mons Lera R.

Rev Esp Anestesiol Reanim. 2012 Mar;59(3):142-9. doi: 10.1016/j.redar.2012.04.002. Epub 2012 May 3. Spanish.

PMID:
22985755
16.

Aerosolized prostacyclin and iloprost in severe pulmonary hypertension.

Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W.

Ann Intern Med. 1996 May 1;124(9):820-4.

PMID:
8610951
17.

Eisenmenger's syndrome: in search of the best vasodilator.

Kuebler WM.

Cardiology. 2013;126(4):252-4. doi: 10.1159/000354937. Epub 2013 Oct 2. No abstract available.

PMID:
24107571
18.

Is it safe to use inhaled iloprost in infants with pulmonary hypertension?

Karaagaç AT, Yildirim AI.

Indian Pediatr. 2013 Nov 8;50(11):1064-5. No abstract available.

19.

Inhaled iloprost is a potent acute pulmonary vasodilator in HIV-related severe pulmonary hypertension.

Ghofrani HA, Friese G, Discher T, Olschewski H, Schermuly RT, Weissmann N, Seeger W, Grimminger F, Lohmeyer J.

Eur Respir J. 2004 Feb;23(2):321-6.

20.

The efficacy and safety of sildenafil in patients with pulmonary arterial hypertension associated with the different types of congenital heart disease.

Zeng WJ, Lu XL, Xiong CM, Shan GL, Liu ZH, Ni XH, Gu Q, Zhao ZH, Li JJ, He JG; Sildenafil Therapy on Pulmonary Arterial Hypertension Associated With Different Types of Congenital Heart Disease Study Group.

Clin Cardiol. 2011 Aug;34(8):513-8. doi: 10.1002/clc.20917. Epub 2011 Jun 15.

Supplemental Content

Support Center